I got a reply. No direct sales to individuals. They want to start with clinical trails in Australia first and will follow a Channel sales model. They might review this at a later stage.
Ann: Ellipta Production and Market Release, page-7
Add ADR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
-0.004(17.4%) |
Mkt cap ! $7.411M | |||
| Open | High | Low | Value | Volume |
| 2.2¢ | 2.2¢ | 1.9¢ | $53.27K | 2.634M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 1041837 | 1.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.9¢ | 564235 | 2 |
View Market Depth
| Last trade - 12.58pm 27/05/2024 (20 minute delay) ? |
|
|||||
|
Last
1.9¢ |
Change
-0.004 ( 14.8 %) |
||||
| Open | High | Low | Volume | ||
| 2.2¢ | 2.2¢ | 1.8¢ | 3599375 | ||
| Last updated 15.04pm 27/05/2024 ? | |||||
| ADR (ASX) Chart |